• India
  • 28 February 2013
  • Opinion
  • By Mr Gautam Khanna

FICCI medical devices forum chair: Budget is a mix bag

Updated on 1 March 2013

Mr Gautam Khanna, chair, medical devices forum, FICCI, and executive director, healthcare business, 3M India, expresses his views on the 2013 Indian Union Budget

mr-gautam-khanna-chair-medical-devices-forum-ficci-and-executive-director-healthcare-business-3m-india

Mr Gautam Khanna, chair, medical devices forum, FICCI, and executive director, healthcare business, 3M India

India's Finance Minister, Mr P Chidambaram, has reiterated that health for all is a priority. The increase in outlay by 21.6 percent for healthcare to $7466 million (Rs 37330 crore) is welcome. The government is moving in the right direction with increase in investment in education and research. Allocation of $30 million (Rs 150 crore) for National Program for Healthcare of Elderly is also a good initiative. Allocation for $330 million (Rs 1650 crore) for the six AIIMS-like institutions is well aligned with the country's expectations of universal healthcare.

Also read:

 

Combining NRHM and NUHM facilities will also ensure uniform implementation of government policies across the country. This is a welcome move as the support required for the urban poor is as important as that for the rural segment. This will ensure a uniform implementation of government policies across the country. However, it would have been better if reforms in health insurance and respites in duty for life saving medical equipments had been considered.

Given that healthcare is an important sector that adds 5.2 percrent to the GDP, I am happy that the government has planned to increase its spending by 21.6 percent from $6140 million (Rs 30702 crore)-to-$7466 million (Rs 37330 crore), which is in line with the PM's commitment.Although the expectation was higher, this is a step in the right direction.

 

Previous 1

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X